BlueCrest Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,054
Closed -$2.96M 256
2023
Q4
$2.62M Sell
24,054
-17,304
-42% -$1.8M 0.1% 133
2023
Q3
$4.26M Buy
41,358
+31,416
+316% +$3.39M 0.19% 84
2023
Q2
$1.15M Buy
+9,942
New +$1.13M 0.04% 139
2020
Q1
Sell
-2,591
Closed -$225K 332
2019
Q4
$225K Sell
2,591
-11,037
-81% -$907K 0.01% 318
2019
Q3
$1.09M Buy
+13,628
New +$1.09M 0.08% 180
2019
Q2
Sell
-18,646
Closed -$1.48M 821
2019
Q1
$1.48M Sell
18,646
-159,209
-90% -$11.9M 0.06% 219
2018
Q4
$13M Buy
177,855
+130,418
+275% +$9.21M 0.67% 25
2018
Q3
$3.21M Buy
47,437
+20,213
+74% +$1.29M 0.09% 162
2018
Q2
$1.58M Sell
27,224
-71,497
-72% -$4.03M 0.04% 383
2018
Q1
$5.13M Buy
98,721
+18,736
+23% +$1.01M 0.16% 126
2017
Q4
$4.29M Buy
79,985
+70,680
+760% +$3.92M 0.12% 172
2017
Q3
$569K Sell
9,305
-12,296
-57% -$745K 0.02% 479
2017
Q2
$1.32M Buy
+21,601
New +$1.31M 0.05% 414
2016
Q4
Sell
-159,797
Closed -$9.52M 802
2016
Q3
$9.52M Buy
159,797
+154,630
+2,993% +$9.04M 0.3% 70
2016
Q2
$284K Buy
+5,167
New +$275K 0.01% 703
2016
Q1
Sell
-12,350
Closed -$622K 1000
2015
Q4
$622K Buy
+12,350
New +$623K 0.03% 519

Other funds holding MRK

BlueCrest Capital Management's MRK Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Merck (MRK) in Q1 2024, closing a stake of 24,054 shares — an estimated $2.96M sold.

BlueCrest Capital Management first reported a position in MRK in Q4 2015 and held it in 16 quarters. The position peaked at $13M in Q4 2018. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • BlueCrest Capital Management reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 24,054 Merck shares in Q1 2024, an estimated $2.96M.
  • BlueCrest Capital Management first reported a position in Merck in Q4 2015 and held it in 16 quarters.
  • BlueCrest Capital Management's Merck position peaked at $13M in Q4 2018.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.